BioLooVitalis is a biopharmaceutical firm headquartered in Singapore Renowned for its pioneering work in the fie d of human therapeutics. BioLooVitalis places a strong emphasis on addressing critical healthcare concerns particularly in the domains of cardiovascular diseases, oncology bone health, and inflammation BioLooVitalis has demonstrated its commitment to data security and integrity by maintaining an effective information security management system (ISMS) based on ISO/IEC 77001 for the past two years. After noticing an increase m failed login attempts over several weeks. bioLooVitalis IT security learn reviewed log data, correlated it with user behavior patterns, and mapped it against known attach vectors to determine potential causes. Based on their findings, they prepared a technical report detailing the nature of the anomalies and submitted it to the compliance function. The compliance team then summarized the findings and presented them to the executive management during the quarterly ISMS performance review. To proactively track system behavior following the spike n failed login attempts. BioLooVitalis's IT security team configured a dashboard showing real time login activity. system response times, and end point availability across departments. This helped the team quickly detect abnormal behavior without waiting formal reporting cycles. Following The implementation of the real time access control dashboard BioLooVitalis internal audit team assessed whether the new processes and tools effectively reduced unauthorized access attempts and met both technical and policy-based requirements. Lastly, the internal auditors collected system-generated access logs, reviewed user access reports, and conducted interviews with IT personnel. These data sources helped them verify whether the new controls were functioning as intended and aligned with internal ISMS objectives. Based on The scenario above, answer the following question.

Which measurement-related role did the compliance team perform at BioLooVitalis? Refer to scenario 8.